FilingIndex
DEF 14AThe Ballot

SELLAS Life Sciences Group, Inc. files DEF 14A

Filed Apr 25, 2022 · 4y ago · Accession 0001104659-22-049655

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
SLS
CIK
1390478
Form type
DEF 14A
Filing date
Apr 25, 2022
Report date
Jun 8, 2022
Document
tm223704-1_def14a.htm
Size
6.4 MB